MSLE
Satellos Bioscience Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$152.84M
P/E Ratio
—
EPS
$-1.70
Beta
1.08
52W High
$13.39
52W Low
$4.52
50-Day MA
$9.26
200-Day MA
$6.96
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Satellos Bioscience Inc. Common Stock
Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company is headquartered in Toronto, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-1.51M |
| EBITDA | $-26.45M |
| Operating Margin | 0.00% |
| Return on Equity | -66.40% |
| Return on Assets | -40.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.80 |
| Price-to-Book | 5.59 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 4.75 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $20.83M |
| Float | $19.41M |
| % Insiders | 6.14% |
| % Institutions | 6.12% |
Analyst Ratings
Consensus ($30.00 target)
2
BuyData last updated: 4/16/2026